Relationship between circulating netrin-1 levels, obesity, prediabetes and newly diagnosed type 2 diabetes

References

• Alberti, K., et al., 2009. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation, 120 (16), 1640–1645.
   PubMed Web of Science ®Google Scholar
• Brown, J.B., Pedula, K.L., and Bakst, A.W., 1999. The progressive cost of complications in type 2 diabetes mellitus. Archives of internal medicine, 159 (16), 1873–1880.
   PubMedGoogle Scholar
• Bruikman, S., et al., 2020. Netrin-1 and the grade of Atherosclerosis are inversely correlated with humans. Arteriosclerosis, thrombosis, and vascular biology, 40 (2), 462–472.
   PubMed Web of Science ®Google Scholar
• De Breuck, S., et al., 2003. Netrin-1 expression in fetal and regenerating rat pancreas and its effect on the migration of human pancreatic duct and porcine islet precursor cells. Diabetologia, 46 (7), 926–933.
   PubMed Web of Science ®Google Scholar
• Dun, X.P., and Parkinson, D.B., 2017. Role of netrin-1 signaling in nerve regeneration. International journal of molecular sciences, 18 (3), 491.
   Web of Science ®Google Scholar
• European Society of Hypertension 2013. 2013 ESH/ESC guidelines for the management of arterial hypertension.
   Google Scholar
• Farmer, A., et al., 2011. Diagnosis, classification, and treatment of diabetes. BMJ (clinical research ed.).), 342, d3319.
   PubMedGoogle Scholar
• Gao, S., et al., 2016. Dual actions of Netrin-1 on islet insulin secretion and immune modulation. Clinical science, 130 (21), 1901–1911.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation (IDF) 2019. IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Federation. Available from: https://www.diabetesatlas.org
   Google Scholar
• Ke, T., et al., 2014. Netrin-1 ameliorates myocardial infarction-induced myocardial injury: mechanisms of action in rats and diabetic mice. Human gene therapy, 25 (9), 787–797.
   PubMed Web of Science ®Google Scholar
• Lee, H.K., et al., 2007. Netrin-1 induces proliferation of Schwann cells through Unc5b receptor. Biochemical and biophysical research communications, 362 (4), 1057–1062.
   PubMed Web of Science ®Google Scholar
• Lin, Z., et al., 2018. Netrin-1 prevents the attachment of monocytes to endothelial cells via an anti-inflammatory effect. Molecular immunology, 103, 166–172.
   PubMed Web of Science ®Google Scholar
• Liu, C., et al., 2016. The level of netrin-1 is decreased in newly diagnosed type 2 diabetes mellitus patients. BMC endocrine disorders, 16 (1), 33.
   PubMedGoogle Scholar
• Liu, N.M., et al., 2017. Attenuation of neointimal formation with netrin-1 and netrin-1 preconditioned endothelial progenitor cells. Journal of molecular medicine (Berlin, Germany)), 95 (3), 335–348.
   PubMed Web of Science ®Google Scholar
• Ly, N.P., et al., 2005. Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proceedings of the national academy of sciences of the United States of America, 102 (41), 14729–14734.
   PubMed Web of Science ®Google Scholar
• Mirakaj, V., et al., 2011. Netrin-1 signaling dampens inflammatory peritonitis. Journal of immunology (Baltimore, MD: 1950)), 186 (1), 549–555.
   PubMed Web of Science ®Google Scholar
• Munoz, J., et al., 2017. Relation between serum levels of chemotaxis-related factors and the presence of coronary artery calcification as expession of subclinical atherosclerosis. Clinical biochemistry, 50 (18), 1048–1055.
   PubMed Web of Science ®Google Scholar
• Oh, D., et al., 2012. Increased macrophage migration into adipose tissue in obese mice. Diabetes, 61 (2), 346–354.
   PubMed Web of Science ®Google Scholar
• Ramkhelawon, B., et al., 2013. Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: mechanism for macrophage retention and survival. Arteriosclerosis, thrombosis, and vascular biology, 33 (6), 1180–1188.
   PubMed Web of Science ®Google Scholar
• Ramkhelawon, B., et al., 2014. Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity. Nature medicine, 20 (4), 377–384.
   PubMed Web of Science ®Google Scholar
• Serafini, T., et al., 1994. The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell, 78 (3), 409–424.
   PubMed Web of Science ®Google Scholar
• Sharma, M., et al., 2019. Netrin-1 alters adipose tissue macrophage fate and function in obesity. Immunometabolism, 1 (2), e190010.
   PubMedGoogle Scholar
• Steinberg, H.O., et al., 1996. Obesity/insulin resitance is associated with endothelial dysfunction. Implications for the syndrome of insuline reistance. Journal of clinical investigation, 97 (11), 2601–2610.
   PubMed Web of Science ®Google Scholar
• Sun, K.L.W., Correia, J.P., and Kennedy, T.E., 2011. Netrins: versatile extracellular cues with diverse functions. Development (Cambridge, England), 138 (11), 2153–2169.
   PubMed Web of Science ®Google Scholar
• Sun, L., et al., 2019. Decreased netrin-1 and correlated Th17/Tregs balance disorder in Aβ1-42 induced Alzheimer’s disease model rats front. Aging neuroscience, 11–124.
   Google Scholar
• Toque, H.A., et al., 2017. Netrin-1 is a novel regulator of vascular endothelial function in diabetes. PLoS One, 12 (10), e0186734.
   PubMed Web of Science ®Google Scholar
• Tu, T., et al., 2015. CD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development. Cell research, 25 (3), 275–287.
   PubMed Web of Science ®Google Scholar
• Van Gils, J.M., et al., 2012. The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nature immunology, 13 (2), 136–143.
   PubMed Web of Science ®Google Scholar
• Van Gils, J.M., et al., 2013. Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions. Arteriosclerosis, thrombosis, and vascular biology, 33 (5), 911–919.
   PubMed Web of Science ®Google Scholar
• Wu, C.H., et al., 2016. Netrin-1 contributes to myelinated afferent fiber sprouting and neuropathic pain. Molecular neurobiology, 53 (8), 5640–5651.
   PubMed Web of Science ®Google Scholar
• Xing, Y., et al., 2017. Netrin-1 restores cell injury and impaired angiogenesis in vascular endothelial cells upon high glucose by PI3K/AKT-eNOS. Journal of molecular endocrinology, 58 (4), 167–177.
   PubMed Web of Science ®Google Scholar
• Yim, J., et al., 2018. Relationship between circulating netrin-1 concentration, impaired fasting glucose, and newly diagnosed type 2 diabetes. Frontiers in endocrinology, 9, 691.
   PubMed Web of Science ®Google Scholar
• Zatalia, S.R., and Sanusi, H., 2013. The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus. Acta medica Indonesiana, 45 (2), 141–147.
   PubMedGoogle Scholar
• Zhang, J., et al., 2015. Matrine improves cognitive impairment and modulates the balance of Th17/Treg cytokines in a rat model of Aβ1-42-induced Alzheimer's disease. Central-European journal of immunology, 40 (4), 411–419.
   PubMed Web of Science ®Google Scholar
• Zimmet, P., Alberti, K.G.M.M., and Shaw, J., 2001. Global and societal implications of the diabetes epidemic. Nature, 414 (6865), 782–787.
   PubMed Web of Science ®Google Scholar